Home › NCT06754514

Organ Retractor Device Study

Boehringer Laboratories Organ Retractor Device Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* undergoing minimally invasive primary bariatric surgery

Exclusion Criteria:

* known liver disease

About the study

This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.

What is being tested

• liver retraction (device)

Sponsor: Boehringer Labs LLC · Participants: 150 · Started: Mar 14, 2024

Contact the study team

• Business Development · Phone: 4849312338

Official record on ClinicalTrials.gov — NCT06754514

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.